Durect Corp. Stock
Price
Target price
-
-
-
-
-
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Durect Corp. Stock
For the coming years our community has positive and negative things to say abot the Durect Corp. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Durect Corp. in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
S********** s********
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Durect Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Durect Corp. | - | - | - | - | - | - | - |
| Heron Therapeutics Inc. | -3.960% | -12.346% | -25.100% | -65.830% | -32.765% | -65.516% | -94.563% |
| Evolus Inc | 0.000% | -4.405% | 17.297% | -62.586% | -20.367% | -45.750% | -60.311% |
| Sangamo Therapeutics Inc. | 1.350% | -6.094% | 6.294% | -61.957% | -4.403% | -82.443% | -96.619% |
Comments
DURECT Co. (NASDAQ: DRRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for DRRX provided by MarketBeat
DURECT Co. (NASDAQ: DRRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for DRRX provided by MarketBeat
DURECT Co. (NASDAQ: DRRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for DRRX provided by MarketBeat